Glenmark Pharmaceuticals Gets CDSCO Panel Nod to Study Lobeglitazone Sulfate, Glimepiride FDC Table
New Delhi: Glenmark Pharmaceuticals, a major pharmaceutical company, has received approval from the Subject Expert Committee (SEC) operating under …
Lorem Ipsum has been the industry's standard dummy text.
New Delhi: Glenmark Pharmaceuticals, a major pharmaceutical company, has received approval from the Subject Expert Committee (SEC) operating under …
USA: A recent study published in the Journal of Clinical Periodontology revealed a significant difference in high-frequency ultrasound (HFUS) echo …
China: A recent meta-analysis published in BMC Ophthalmology has revealed worse sleep quality in individuals with dry eye than in the healthy popul…
Denmark: In patients with hip osteoarthritis (OA), progressive resistance training (PRT) is not superior to neuromuscular exercise (NEMEX) for impro…
New research indicates that physical activity lowers cardiovascular disease risk in part by reducing stress-related signaling in the brain. In the…
AstraZeneca's FASENRA® (benralizumab) is now approved by the US Food and Drug Administration (FDA) for add-on maintenance treatment for patient…
In a notable study conducted across three hospitals, researchers have discovered a potentially game-changing approach to combatting the alarming ris…
Lorem Ipsum is simply dummy text of the printing and typesetting has been the industry's.